Risk Factors for Parkinson's Disease

The risk of developing Parkinson's disease is influenced by a combination of non-modifiable factors — including age, sex, genetics, and family history — and modifiable factors such as pesticide and solvent exposure, physical activity, head trauma, and diet. Having one or more risk factors does not mean a person will develop Parkinson's disease, and many people diagnosed with PD have no identifiable risk factors beyond age. Understanding these factors helps researchers develop prevention strategies and helps individuals make informed health decisions.

Non-Modifiable Risk Factors

These are factors that cannot be changed but are important to understand for risk assessment, genetic counseling, and research.

Age

Age is the single strongest risk factor for Parkinson's disease. The average age of diagnosis is around 60, and the incidence rises steeply with each decade of life. Parkinson's is rare before age 50, affecting roughly 4 per 100,000 people in that age group. After age 60, prevalence rises to approximately 1 percent, and by age 80, approximately 3 to 4 percent of the population is affected.

Aging contributes to PD risk through multiple biological mechanisms: cumulative oxidative damage to dopaminergic neurons, declining mitochondrial function and energy production, reduced capacity for protein clearance (autophagy and lysosomal degradation), progressive loss of neuronal repair mechanisms, and the gradual natural attrition of dopaminergic neurons that occurs even in healthy aging — though at a far slower rate than in Parkinson's. Age-related chronic low-grade inflammation (“inflammaging”) may also create a permissive environment for neurodegeneration.

Sex

Men are approximately 1.5 times more likely to develop Parkinson's disease than women. This sex disparity is one of the most consistent findings in PD epidemiology and has been observed across populations worldwide. The reasons are multifactorial:

• Estrogen. Estrogen has demonstrated neuroprotective properties in laboratory studies, including antioxidant effects, promotion of dopaminergic neuron survival, and modulation of neuroinflammation. Some epidemiological evidence suggests that women who undergo early menopause, bilateral oophorectomy (surgical removal of ovaries), or who have shorter reproductive lifespans have higher PD risk — consistent with a protective estrogen hypothesis. However, randomized trials of hormone replacement therapy for PD prevention have not been conducted.
• Environmental exposure. Men are more likely to have occupational exposure to pesticides, industrial solvents, and heavy metals — established environmental risk factors for PD. In agricultural communities, the sex disparity in PD incidence is even more pronounced.
• Genetic modifiers. Some PD-associated genetic variants appear to interact differently with sex hormones and X-linked genes, potentially influencing risk differently in men and women.
• Diagnostic bias. Women with PD may be underdiagnosed or diagnosed later than men, partly because tremor-dominant presentations (more common in women) may be initially attributed to essential tremor.

Family History and Genetics

Having a first-degree relative (parent or sibling) with Parkinson's disease approximately doubles your risk compared to the general population. However, the absolute risk remains low: if the general population lifetime risk is about 2 percent, having an affected first-degree relative raises it to roughly 4 to 5 percent. Having two or more affected relatives increases the risk further but is uncommon.

Specific genetic mutations carry substantially higher risks:

• LRRK2 G2019S carriers: 25 to 40 percent lifetime risk of developing PD, with higher penetrance in certain populations (Ashkenazi Jewish, North African Arab Berber).
• GBA1 mutation carriers: 5 to 30 percent lifetime risk depending on the specific mutation, with more severe mutations conferring higher risk. GBA1 variants are found in 10 to 15 percent of sporadic PD cases — making this the most common genetic risk factor for Parkinson's disease.
• SNCA mutations or multiplications: High penetrance but extremely rare. Gene duplications and triplications cause aggressive disease.
• PRKN (Parkin), PINK1, DJ-1: Autosomal recessive inheritance; primarily cause early-onset PD (before age 40-50). Two mutated copies are needed for disease.

Beyond these monogenic forms, genome-wide association studies have identified more than 90 common genetic variants that each contribute a small increase in PD risk. Polygenic risk scores — combining the effects of many common variants — are being developed as research tools to estimate cumulative genetic risk, but are not yet used in routine clinical practice.

Ethnicity

Studies in the United States have found that White and Hispanic individuals are diagnosed with PD at higher rates than Black and Asian individuals. However, researchers caution that these differences may partly reflect disparities in access to neurological care, diagnostic bias, and study recruitment patterns rather than true biological differences. A 2020 study found that when standardized screening tools were applied equally, racial disparities in PD diagnosis narrowed considerably. The Parkinson's Foundation has identified health equity in PD diagnosis and care as a priority research area.

Modifiable Risk Factors — Exposures That Increase Risk

These are factors that can potentially be reduced or avoided. While modifying these factors cannot guarantee prevention, the evidence supports taking reasonable precautions.

Pesticide and Herbicide Exposure

Chronic exposure to certain agricultural chemicals is one of the best-established environmental risk factors. Meta-analyses have found that pesticide exposure is associated with roughly a 60 percent increase in PD risk. The chemicals most strongly implicated include:

• Paraquat. A widely used herbicide that generates massive oxidative stress. Exposure is associated with approximately double the risk of PD. Paraquat remains legal in the U.S. despite being banned in the EU and over 30 other countries.
• Rotenone. An insecticide and piscicide (fish poison) that directly inhibits mitochondrial complex I. So reliably toxic to dopaminergic neurons that it is used in laboratory research to create animal models of Parkinson's disease.
• Organochlorine pesticides. Including dieldrin, lindane, and beta-HCH. These are persistent organic pollutants that accumulate in body tissues over years to decades.

The risk is highest among farmers, agricultural workers, and people living near agricultural areas. Rural residence and well water consumption — both proxies for pesticide exposure — are independently associated with increased PD risk. The dose-response relationship (more exposure = more risk) and the biological plausibility (pesticides directly damage dopaminergic neurons through known mechanisms) strengthen the causal case.

Industrial Solvents

Trichloroethylene (TCE) is an industrial solvent used in metal degreasing, dry cleaning, and manufacturing since the 1920s. Epidemiological studies have consistently linked TCE exposure to significantly increased PD risk. TCE is particularly insidious because it contaminates groundwater and soil and evaporates from contaminated water into indoor air, meaning exposure can occur in homes and workplaces without awareness.

A 2023 study published in JAMA Neurology examined Marines stationed at Camp Lejeune, where the water supply was contaminated with TCE and related chemicals for decades. The study found a roughly 70 percent higher rate of Parkinson's disease among exposed veterans. TCE is estimated to have contaminated thousands of sites across the United States, and the EPA classifies it as a known human carcinogen. Other solvents associated with increased PD risk include perchloroethylene (PERC, used in dry cleaning) and carbon tetrachloride.

Head Trauma

A history of traumatic brain injury (TBI) is associated with an increased risk of Parkinson's, with the risk rising with the severity and frequency of injuries. A large population-based study found that a single moderate-to-severe TBI increases PD risk by approximately 50 percent. Repeated mild TBIs — as sustained in contact sports like boxing, football, and soccer — carry a similar or greater elevation. The mechanism likely involves triggering neuroinflammatory cascades, disrupting the blood-brain barrier, and accelerating alpha-synuclein pathology and aggregation.

Air Pollution

Emerging evidence links long-term exposure to fine particulate matter (PM2.5) and nitrogen dioxide with increased PD risk. Some epidemiological studies have associated higher long-term PM2.5 or nitrogen dioxide exposure with a modest increase in Parkinson's disease incidence, though findings have been inconsistent across cohorts and the evidence remains emerging rather than definitive. The proposed mechanisms include systemic inflammation, oxidative stress, and direct neurotoxicity from ultrafine particles that may enter the brain via the olfactory nerve or the bloodstream. This emerging risk factor is particularly concerning in rapidly industrializing regions of the world, where PM2.5 levels far exceed WHO guidelines.

Modifiable Factors — Associated with Reduced Risk

Some factors appear to lower the probability of developing Parkinson's disease. These findings come from large epidemiological studies and do not necessarily prove causation, but the consistency of the associations across multiple studies and populations provides reasonable grounds for actionable recommendations.

Physical Activity

Regular moderate-to-vigorous physical activity is associated with a 30 to 40 percent reduction in PD risk in multiple large prospective cohort studies. This is one of the most actionable protective factors with the strongest evidence base. The protective mechanism likely involves exercise-induced increases in neurotrophic factors (such as BDNF and GDNF), improved mitochondrial function and biogenesis, reduced oxidative stress, anti-inflammatory effects, and enhanced neuroplasticity.

Beyond prevention, exercise also appears to slow progression in people already diagnosed with PD. A 2023 Cochrane review of 156 randomized controlled trials (7,939 participants) found small-to-large effects across multiple exercise types — including aerobic exercise, resistance training, tai chi, and dance — on motor function and quality of life. The evidence is strong enough that regular vigorous exercise is now considered a core component of Parkinson's disease management, not merely a supplement.

Caffeine Consumption

Coffee and tea drinkers have a 25 to 30 percent lower risk of Parkinson's disease compared to non-consumers. This association has been replicated in multiple large prospective studies across different populations and appears to be dose-dependent — more caffeine intake is associated with greater risk reduction, up to a plateau. The protective effect is thought to be mediated by caffeine's blockade of adenosine A2A receptors in the basal ganglia, which modulates dopaminergic signaling and may reduce neuroinflammation.

Interestingly, the protective effect of caffeine appears to be stronger in men than in women, possibly due to interactions with estrogen. In postmenopausal women taking hormone replacement therapy, the caffeine-PD risk reduction may be attenuated or absent, while in women not taking HRT, the protective effect is similar to men.

Smoking (Strongly Not Recommended)

Smoking tobacco is associated with approximately a 40 percent reduction in PD risk — one of the most consistent and counterintuitive findings in Parkinson's epidemiology, observed across dozens of studies over several decades. The mechanism is uncertain but may involve nicotine's stimulation of dopaminergic pathways, inhibition of monoamine oxidase (MAO) by non-nicotine components of tobacco smoke, and potential anti-inflammatory effects.

However, researchers, clinicians, and public health organizations universally and emphatically emphasize that the devastating health consequences of smoking — cancer, heart disease, stroke, COPD, and premature death — far outweigh any potential neuroprotective benefit. Smoking is not recommended as a Parkinson's prevention strategy under any circumstances. Research into nicotinic receptor agonists (drugs that target the same receptors as nicotine without the toxicity of tobacco) is ongoing but has not yet produced clinically validated results.

Anti-Inflammatory Medications

Some epidemiological studies have found that regular use of ibuprofen is associated with a modestly reduced PD risk (approximately 15 to 25 percent reduction in some analyses), possibly reflecting the role of neuroinflammation in disease pathogenesis. This association has not been consistently observed with other NSAIDs (naproxen, aspirin, acetaminophen). The evidence is not strong enough to recommend ibuprofen use for PD prevention, particularly given the gastrointestinal, cardiovascular, and renal risks of chronic NSAID use.

Diet

The Mediterranean diet — rich in fruits, vegetables, whole grains, olive oil, nuts, and fish — has been associated with reduced PD risk in several meta-analyses. The proposed mechanisms include anti-inflammatory effects, antioxidant protection, and beneficial effects on the gut microbiome. However, the evidence is observational (no randomized trials of diet for PD prevention exist), and only specific components of the diet may drive the observed association. A healthy diet is universally recommended for general health and may confer additional neuroprotective benefits.

Risk Factors: Modifiable vs. Non-Modifiable Summary

Practical Implications

No single risk factor determines whether a person will develop Parkinson's disease. The current scientific understanding is that PD results from a complex interaction between genetic susceptibility, environmental exposures, and aging — a “multiple hit” model. For most people, the modifiable risk factors with the strongest evidence and most practical application are:

1. Regular physical exercise (associated with 30 to 40 percent risk reduction, and demonstrated to slow progression after diagnosis)
2. Avoiding unnecessary pesticide and solvent exposure (protective equipment, awareness of contaminated sites, proper ventilation)
3. Head injury prevention (helmets for cycling and contact sports, fall prevention in older adults)
4. Moderate caffeine consumption (associated with 25 to 30 percent risk reduction; no adverse effects at moderate intake)
5. Mediterranean-style diet (observational evidence for reduced risk; strong evidence for general health benefits)

If you have a family history of Parkinson's disease or carry a known risk gene, genetic counseling can help you understand your individual risk profile and make informed decisions about monitoring, lifestyle modifications, and potential participation in prevention research. The Michael J. Fox Foundation's PD GENEration program offers free genetic testing for people with Parkinson's and genetic counseling support.